ARCHIVES

White House FY 1979 Budget Probably Will give NCI $900 Million; NCAB Objects To ’78 Allocations

This article is from The Cancer Letter archive.

Vol. 03 No. 47 | November 25, 1977

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

Should Be Cut First, DCT Board Says

December 4, 1981

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013